Bristol-Myers Squibb Company (ETR:BRM)
Germany
· Delayed Price · Currency is EUR 45.07
+0.66 (1.49%)
At close: Dec 5, 2025
ETR:BRM Revenue
Bristol-Myers Squibb Company had revenue of $12.22B USD in the quarter ending September 30, 2025, with 2.77% growth. This brings the company's revenue in the last twelve months to $48.03B, up 1.26% year-over-year. In the year 2024, Bristol-Myers Squibb Company had annual revenue of $48.30B with 7.32% growth.
Revenue (ttm)
$48.03B
Revenue Growth
+1.26%
P/S Ratio
2.23
Revenue / Employee
$1.41M
Employees
34,100
Market Cap
91.26B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 48.30B | 3.29B | 7.32% |
| Dec 31, 2023 | 45.01B | -1.15B | -2.50% |
| Dec 31, 2022 | 46.16B | -226.00M | -0.49% |
| Dec 31, 2021 | 46.39B | 3.87B | 9.09% |
| Dec 31, 2020 | 42.52B | 16.37B | 62.62% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.27B |
| Siemens Healthineers AG | 23.38B |
| Bayer Aktiengesellschaft | 45.87B |
| Fresenius SE & Co. KGaA | 22.45B |
| Sartorius Aktiengesellschaft | 3.52B |
| Fresenius Medical Care AG | 19.64B |
| Carl Zeiss Meditec AG | 2.18B |
| Fielmann Group AG | 2.42B |
Bristol-Myers Squibb Company News
- 1 day ago - Bristol Myers' Cancer Breakthrough Breyanzi Just Won Its Fifth FDA Approval - Benzinga
- 1 day ago - FDA Approves Bristol Myers' Breyanzi For Relapsed/Refractory Marginal Zone Lymphoma - Nasdaq
- 1 day ago - FDA Approves Bristol Myers Squibb's Breyanzi As First CAR T Therapy For R/R Marginal Zone Lymphoma - Nasdaq
- 1 day ago - Bristol Myers (BMY) Receives FDA Approval for New Cancer Therapy - GuruFocus
- 1 day ago - Bristol-Myers Squibb Company (BMY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 1 day ago - Bristol-Myers Squibb Co at Citi Global Healthcare Conference Transcript - GuruFocus
- 2 days ago - BMY Gains on News of Continuation of Alzheimer's Disease Study - Nasdaq
- 2 days ago - Bristol Myers (BMY) to Expand ADEPT-2 Study Enrollment - GuruFocus